The Global Radiotherapy Market, by Product Type (Systemic Radiation, External Beam Radiation, and Internal Beam Radiation), by Therapy Type (Systemic Radiation Therapy, External Beam Radiation Therapy, and Internal Beam Radiation Therapy), by Application (Cervical Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), by End User (Ambulatory Radiotherapy Centers, Hospitals, and Oncology Clinics), and by Region (North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa) had a market valuation of US$ 5,253.7 million in 2016 and is anticipated to grow at a CAGR of 6.8 percent during the forecast period (2017 – 2025).
Request Sample Copy of Radiotherapy Report @ https://www.coherentmarketinsights.com/insight/request-sample/1320
Since radiation is a very effective and cheap cancer treatment, the market for radiotherapy is projected to grow significantly. Recent improvements in radiation procedures to improve treatment accuracy with regulatory agency clearance are a significant factor driving the global radiotherapy market expansion. Hitachi Ltd. gained FDA approval for the introduction and marketing of the Real Time Image Gating System for Proton Beam Therapy Systems (RGPT) in 2017, allowing patients to benefit from sophisticated spot imaging irradiation technology. Hokkaido University Hospital and the Clinical Research and Medical Innovation Center collaborated to build the system. A growing number of research organizations are partnering to investigate targeted systemic treatments for the improvement of radiotherapy technology, potentially influencing market growth. The Clinical and Translational Radiation Research Working Group (CTRad) was established by the National Collaborative Research Infrastructure Strategy (NCRI) to advance the nationwide radiotherapy research program.
To expedite innovation and extend their geographical reach, key companies are engaging in strategic alliances and mergers for the advancement of radiation procedures, therefore increasing market growth. Ion Beam Applications and Royal Philips partnered in 2017 to offer innovative integrated solutions for proton therapy and molecular imaging centers, with the goal of enabling successful and customized cancer care. Proteus ONE and Proteus PLUS proton treatment systems, as well as healthcare information technologies such as Philips Big Bore CT, PET CT systems, and Pi, were developed in collaboration. Main players are releasing high-quality instruments for precise and effective radiation treatment, resulting in the introduction of innovative solutions to improve cancer radiotherapy. Toshiba Medical released the Galan RT Solutions suite of radiation treatment tools in 2017, which includes Civco Radiotherapy’s innovative Universal Couchtop MR Overlay to assist enhance patient safety by protecting healthy tissue from unwanted radiation.
Key Takeaways
The global radiotherapy market is anticipated to grow at a 6.8 percent CAGR during the forecast period, due to rising oncologist prescriptions since radiotherapy has a greater potential to remove cancer, as well as rising cancer incidence in Europe, Asia Pacific, and Latin America.
Due to the increased use of linear accelerators, product improvements, and growing influence of external beam radiotherapy equipment in developing countries such as India, Brazil, and China, the external beam radiation sector maintains a dominating position in the global radiotherapy market.
Due to the increased number of patients diagnosed with the disease and the rising availability of novel external and internal beam radiotherapies to treat the ailment, the lung sector has a dominating position in the global radiotherapy market.
Due to the greater acceptance and accessibility of sophisticated radiation systems that provide better treatment, hospitals maintain a dominating position among end users.
Request PDF Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1320
Key companies contributing in the global radiotherapy market are Ion Beam Applications S.A., Isoray Medical, Inc., Elekta AB, Varian Medical Systems, Inc., Accuray Incorporated, ProTom International, Inc., Mevion Medical Systems, Inc., Hitachi Ltd., CIVCO Radiotherapy, and C.R. Bard, Inc.
Table Of Content
Chapter No. 1 Introduction
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP & Key Offerings
1.2. Key Benefits for Stakehulders
1.3. Target Audience
1.4. Report Scope
Chapter No. 2 Executive Summary
2.1. Key Findings
2.1.1. Top Investment Pockets
2.1.1.1. Market Attractiveness Analysis, By Type
2.1.1.2. Market Attractiveness Analysis, By End Use
2.1.1.3. Market Attractiveness Analysis, By Region
2.2. Market Snapshot
2.3. Global Radiotherapy Market, 2016 – 2021 (USD Million)
2.4. Insights from Primary Respondents
Chapter No. 3 COVID 19 Impact Analysis
3.1. Impact Assessment of COVID-19 Pandemic, By Region
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. The Middle-East and Africa
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1320
Reasons to Purchase this Report
• Current and future of global Radiotherapy market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Key Questions Answered in This Report on Radiotherapy Market
• How much revenue will the global Radiotherapy Market generate by the end of the forecast period?
• What regions currently contribute the maximum share to the overall Radiotherapy Market?
• What are the indicators expected to drive the global Radiotherapy Market?
• Which region is likely to be a lucrative market during the forecast period?
• What are the essential strategies incorporated by key stakeholders in the global Radiotherapy Market to expand their geographical presence?
• What are the major advancements witnessed in the global Radiotherapy Market?
• This report answers these questions and more about the global Radiotherapy Market, aiding major stakeholders and key players in making the right decisions and strategizing for the advancement of their business.
Customization of the Report
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Also, Research Report Examines:
• Competitive companies and manufacturers in global market
• By Product Type, Applications & Growth Factors
• Industry Status and Outlook for Major Applications / End Users / Usage Area
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
The post Radiotherapy Market Business Perspective, Opportunities 2017-2025 | Accuray Incorporated, Varian Medical Systems, Inc., Elekta AB appeared first on Gatorledger.
The Global Radiotherapy Market, by Product Type (Systemic Radiation, External Beam Radiation, and Internal Beam Radiation), by Therapy Type (Systemic Radiation Therapy, External Beam Radiation Therapy, and Internal Beam Radiation Therapy), by Application (Cervical Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), by End User (Ambulatory Radiotherapy Centers, Hospitals, and Oncology Clinics), and by Region (North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa) had a market valuation of US$ 5,253.7 million in 2016 and is anticipated to grow at a CAGR of 6.8 percent during the forecast period (2017 – 2025).
Request Sample Copy of Radiotherapy Report @ https://www.coherentmarketinsights.com/insight/request-sample/1320
Since radiation is a very effective and cheap cancer treatment, the market for radiotherapy is projected to grow significantly. Recent improvements in radiation procedures to improve treatment accuracy with regulatory agency clearance are a significant factor driving the global radiotherapy market expansion. Hitachi Ltd. gained FDA approval for the introduction and marketing of the Real Time Image Gating System for Proton Beam Therapy Systems (RGPT) in 2017, allowing patients to benefit from sophisticated spot imaging irradiation technology. Hokkaido University Hospital and the Clinical Research and Medical Innovation Center collaborated to build the system. A growing number of research organizations are partnering to investigate targeted systemic treatments for the improvement of radiotherapy technology, potentially influencing market growth. The Clinical and Translational Radiation Research Working Group (CTRad) was established by the National Collaborative Research Infrastructure Strategy (NCRI) to advance the nationwide radiotherapy research program.
To expedite innovation and extend their geographical reach, key companies are engaging in strategic alliances and mergers for the advancement of radiation procedures, therefore increasing market growth. Ion Beam Applications and Royal Philips partnered in 2017 to offer innovative integrated solutions for proton therapy and molecular imaging centers, with the goal of enabling successful and customized cancer care. Proteus ONE and Proteus PLUS proton treatment systems, as well as healthcare information technologies such as Philips Big Bore CT, PET CT systems, and Pi, were developed in collaboration. Main players are releasing high-quality instruments for precise and effective radiation treatment, resulting in the introduction of innovative solutions to improve cancer radiotherapy. Toshiba Medical released the Galan RT Solutions suite of radiation treatment tools in 2017, which includes Civco Radiotherapy’s innovative Universal Couchtop MR Overlay to assist enhance patient safety by protecting healthy tissue from unwanted radiation.
Key Takeaways
The global radiotherapy market is anticipated to grow at a 6.8 percent CAGR during the forecast period, due to rising oncologist prescriptions since radiotherapy has a greater potential to remove cancer, as well as rising cancer incidence in Europe, Asia Pacific, and Latin America.
Due to the increased use of linear accelerators, product improvements, and growing influence of external beam radiotherapy equipment in developing countries such as India, Brazil, and China, the external beam radiation sector maintains a dominating position in the global radiotherapy market.
Due to the increased number of patients diagnosed with the disease and the rising availability of novel external and internal beam radiotherapies to treat the ailment, the lung sector has a dominating position in the global radiotherapy market.
Due to the greater acceptance and accessibility of sophisticated radiation systems that provide better treatment, hospitals maintain a dominating position among end users.
Request PDF Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1320
Key companies contributing in the global radiotherapy market are Ion Beam Applications S.A., Isoray Medical, Inc., Elekta AB, Varian Medical Systems, Inc., Accuray Incorporated, ProTom International, Inc., Mevion Medical Systems, Inc., Hitachi Ltd., CIVCO Radiotherapy, and C.R. Bard, Inc.
Table Of Content
Chapter No. 1 Introduction
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP & Key Offerings
1.2. Key Benefits for Stakehulders
1.3. Target Audience
1.4. Report Scope
Chapter No. 2 Executive Summary
2.1. Key Findings
2.1.1. Top Investment Pockets
2.1.1.1. Market Attractiveness Analysis, By Type
2.1.1.2. Market Attractiveness Analysis, By End Use
2.1.1.3. Market Attractiveness Analysis, By Region
2.2. Market Snapshot
2.3. Global Radiotherapy Market, 2016 – 2021 (USD Million)
2.4. Insights from Primary Respondents
Chapter No. 3 COVID 19 Impact Analysis
3.1. Impact Assessment of COVID-19 Pandemic, By Region
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. The Middle-East and Africa
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1320
Reasons to Purchase this Report
• Current and future of global Radiotherapy market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Key Questions Answered in This Report on Radiotherapy Market
• How much revenue will the global Radiotherapy Market generate by the end of the forecast period?
• What regions currently contribute the maximum share to the overall Radiotherapy Market?
• What are the indicators expected to drive the global Radiotherapy Market?
• Which region is likely to be a lucrative market during the forecast period?
• What are the essential strategies incorporated by key stakeholders in the global Radiotherapy Market to expand their geographical presence?
• What are the major advancements witnessed in the global Radiotherapy Market?
• This report answers these questions and more about the global Radiotherapy Market, aiding major stakeholders and key players in making the right decisions and strategizing for the advancement of their business.
Customization of the Report
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Also, Research Report Examines:
• Competitive companies and manufacturers in global market
• By Product Type, Applications & Growth Factors
• Industry Status and Outlook for Major Applications / End Users / Usage Area
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
The post Radiotherapy Market Business Perspective, Opportunities 2017-2025 | Accuray Incorporated, Varian Medical Systems, Inc., Elekta AB appeared first on Gatorledger.